Mumps risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Risk factors for mumps include: unvaccinated individuals who do not have evidence of [[immunity]], belonging to the age group 2-12 years, international travel, especially to countries without mumps vaccination programs, working or living in close proximity to individual(s) infected with Rubulavirus, and being in states of [[immunodeficiency]]. | |||
==Risk Factors== | ==Risk Factors== | ||
Revision as of 16:34, 10 March 2016
|
Mumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mumps risk factors On the Web |
|
American Roentgen Ray Society Images of Mumps risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]; Nate Michalak, B.A.
Overview
Risk factors for mumps include: unvaccinated individuals who do not have evidence of immunity, belonging to the age group 2-12 years, international travel, especially to countries without mumps vaccination programs, working or living in close proximity to individual(s) infected with Rubulavirus, and being in states of immunodeficiency.
Risk Factors
- Unvaccinated individuals who do not have evidence of immunity.
- Acceptable presumptive evidence of immunity to mumps includes: documented administration of two doses of live mumps virus vaccine at least 28 days apart, on or after the first birthday; laboratory evidence of immunity; birth before 1957; or documentation of physician-diagnosed mumps.
- Individuals with only 1 dose of the MMR or MMRV vaccine are at higher risk than those with 2 doses.
- Individuals with 2 doses of the MMR or MMRV vaccine are still at risk since the vaccines are not 100% effective at preventing mumps.
- Children between 2 and 12 years old are at the highest risk for contracting mumps.
- International travel, especially to countries without mumps vaccination programs.[1]
- Working or living in close proximity to individual(s) infected with Rubulavirus (e.g. classrooms, college dormatories).
- Individuals in states of immunodeficiency.[2]
References
- ↑ Galazka AM, Robertson SE, Kraigher A (1999). "Mumps and mumps vaccine: a global review". Bull World Health Organ. 77 (1): 3–14. PMC 2557572. PMID 10063655.
- ↑ Mumps. Centers for Disease Control and Prevention (May 29, 2015). http://www.cdc.gov/mumps/index.html Accessed March 09, 2016.